322
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye

, , , , &
Pages 350-358 | Received 18 Apr 2021, Accepted 12 Aug 2021, Published online: 08 Sep 2021

References

  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf 2017;15:276–283.
  • Gomes JAP, Santo RM. The impact of dry eye disease treatment on patient satisfaction and quality of life: a review. Ocul Surf 2019;17:9–19.
  • Skalicky SE, Petsoglou C, Gurbaxani A, et al. New agents for treating dry eye syndrome. Curr Allergy Asthma Rep 2013;13:322–328.
  • Meadows M. Dealing with dry eye. FDA Consum 2005;39:8–9.
  • Alves M, Fonseca EC, Alves MF, et al. Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies. Ocul Surf 2013;11:181–192.
  • O'Neil EC, Henderson M, Massaro-Giordano M, et al. Advances in dry eye disease treatment. Curr Opin Ophthalmol 2019;30:166–178.
  • Mun Y, Kwon JW, Oh JY. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease. BMC Ophthalmol 2018;18:237.
  • Baek J, Doh SH, Chung SK. The effect of topical diquafosol tetrasodium 3% on dry eye after cataract surgery. Curr Eye Res 2016;41:1281–1285.
  • Mori Y, Nejima R, Masuda A, et al. Effect of diquafosol tetrasodium eye drop for persistent dry eye after laser in situ keratomileusis. Cornea 2014;33:659–662.
  • Dogru M, Kojima T, Simsek C, et al. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Vis Sci 2018;59:DES163–DES168.
  • Choi W, Lee JB, Cui L, et al. Therapeutic efficacy of topically applied antioxidant medicinal plant extracts in a mouse model of experimental dry eye. Oxid Med Cell Longev 2016;2016:4727415.
  • Lee HS, Choi JH, Cui L, et al. Anti-inflammatory and antioxidative effects of Camellia japonica on human corneal epithelial cells and experimental dry eye: in vivo and in vitro study. Invest Ophthalmol Vis Sci 2017;58:1196–1207.
  • Cui L, Lee HS, Li Y, et al. Experimental and clinical applications of Chamaecyparis obtusa extracts in dry eye disease. Oxid Med Cell Longev 2017;2017:4523673.
  • Li L, Jin R, Li Y, et al. Effects of Eurya japonica extracts on human corneal epithelial cells and experimental dry eye. Exp Ther Med 2020;20:1607–1615.
  • Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life 2019;71:487–494.
  • Abraham A, Kattoor AJ, Saldeen T, et al. Vitamin E and its anticancer effects. Crit Rev Food Sci Nutr 2019;59:2831–2838.
  • Napolitano G, Fasciolo G, Di Meo S, et al. Vitamin E supplementation and mitochondria in experimental and functional hyperthyroidism: a mini-review. Nutrients 2019;11:2900.
  • Ribeiro A, Sandez-Macho I, Casas M, et al. Poloxamine micellar solubilization of α-tocopherol for topical ocular treatment. Colloids Surf B Biointerfaces 2013;103:550–557.
  • Xin J, Tang J, Bu M, et al. A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy. Drug Dev Ind Pharm 2016;42:525–534.
  • Jiang Q, Ames BN. Gamma-tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. Faseb J 2003;17:816–822.
  • Salinthone S, Kerns AR, Tsang V, et al. α-Tocopherol (vitamin E) stimulates cyclic AMP production in human peripheral mononuclear cells and alters immune function. Mol Immunol 2013;53:173–178.
  • Simsek C, Kojima T, Dogru M, et al. Alterations of murine subbasal corneal nerves after environmental dry eye stress. Invest Ophthalmol Vis Sci 2018;59:1986–1995.
  • Yoon KC, Ahn KY, Choi W, et al. Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Invest Ophthalmol Vis Sci 2011;52:7267–7273.
  • Pauly A, Brignole-Baudouin F, Labbé A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci 2007;48:5473–5483.
  • Remeseiro B, Bolon-Canedo V, Peteiro-Barral D, et al. A methodology for improving tear film lipid layer classification. IEEE J Biomed Health Inform 2014;18:1485–1493.
  • Yokoi N, Takehisa Y, Kinoshita S. Correlation of tear lipid layer interference patterns with the diagnosis and severity of dry eye. Am J Ophthalmol 1996;122:818–824.
  • Yoon KC, De Paiva CS, Qi H, et al. Expression of Th-1 chemokines and chemokine receptors on the ocular surface of C57BL/6 mice: effects of desiccating stress. Invest Ophthalmol Vis Sci 2007;48:2561–2569.
  • Oh HJ, Li Z, Park SH, et al. Effect of hypotonic 0.18% sodium hyaluronate eyedrops on inflammation of the ocular surface in experimental dry eye. J Ocul Pharmacol Ther 2014;30:533–542.
  • Li Y, Cui L, Lee HS, et al. Comparison of 0.3% hypotonic and isotonic sodium hyaluronate eye drops in the treatment of experimental dry eye. Curr Eye Res 2017;42:1108–1114.
  • Foulks GN. The correlation between the tear film lipid layer and dry eye disease. Surv Ophthalmol 2007;52:369–374.
  • Zhou L, Beuerman RW. Tear analysis in ocular surface diseases. Prog Retin Eye Res 2012;31:527–550.
  • Tsubota K, Yokoi N, Watanabe H, et al. A new perspective on dry eye classification: proposal by the asia dry eye society. Eye Contact Lens 2020;46 Suppl 1:S2–S13.
  • Uchino Y, Kawakita T, Ishii T, et al. A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea 2012;31 Suppl 1:S63–S67.
  • Park JH, Moon SH, Kang DH, et al. Diquafosol sodium inhibits apoptosis and inflammation of corneal epithelial cells via activation of erk1/2 and RSK: in vitro and in vivo dry eye model. Invest Ophthalmol Vis Sci 2018;59:5108–5115.
  • Kojima T, Dogru M, Ibrahim OM, et al. The effects of 3% diquafosol sodium application on the tear functions and ocular surface of the Cu,Zn-superoxide dismutase-1 (Sod1)-knockout mice. Mol Vis 2014;20:929–938.
  • Wu D, Chen WQ, Li R, et al. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials. Cornea 2015;34:644–650.
  • Fukuoka S, Arita R. Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study. Sci Rep 2019;9:9091.
  • Garrigue JS, Amrane M, Faure MO, et al. Relevance of lipid-based products in the management of dry eye disease. J Ocul Pharmacol Ther 2017;33:647–661.
  • Nam YS, Kim JW, Park J, et al. Tocopheryl acetate nanoemulsions stabilized with lipid-polymer hybrid emulsifiers for effective skin delivery. Colloids Surf B Biointerfaces 2012;94:51–57.
  • Zondlo Fiume M. Final report on the safety assessment of tocopherol, tocopheryl acetate, tocopheryl linoleate, tocopheryl linoleate/oleate, tocopheryl nicotinate, tocopheryl succinate, dioleyl tocopheryl methylsilanol, potassium ascorbyl tocopheryl phosphate, and tocophersolan. Int J Toxicol 2002;21:51–116.
  • Maïssa C, Guillon M, Simmons P, et al. Effect of castor oil emulsion eyedrops on tear film composition and stability. Cont Lens Anterior Eye 2010;33:76–82.
  • Choi JH, Kim JH, Li Z, et al. Efficacy of the mineral oil and hyaluronic acid mixture eye drops in murine dry eye. Korean J Ophthalmol 2015;29:131–137.
  • Burton GW, Traber MG. Vitamin E: antioxidant activity, biokinetics, and bioavailability. Annu Rev Nutr 1990;10:357–382.
  • Traber MG. Vitamin E regulatory mechanisms. Annu Rev Nutr 2007;27:347–362.
  • Smolarek AK, Suh N. Chemopreventive activity of vitamin E in breast cancer: a focus on γ- and δ-tocopherol. Nutrients 2011;3:962–986.
  • Smolarek AK, So JY, Thomas PE, et al. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Mol Carcinog 2013;52:514–525.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.